Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosis.
A pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Kinetic Characterization of Ebselen, Chelerythrine and Apomorphine as Glutaminase Inhibitors.
Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
Pediatric Inflammatory Diseases. Part II: Acute Post-Infectious Immune Disorders.
Fatigue in multiple sclerosis is not due to sleep apnoea.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
The current role of mitoxantrone in the treatment of multiple sclerosis.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.
Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Modeling the course and outcomes of MS is statistical twaddle-No.
Botulinum Toxin Treatment of Spasticity in Adults and Children.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Panic disorder as presenting symptoms of multiple sclerosis.
Pages
« first
‹ previous
…
550
551
552
553
554
555
556
557
558
…
next ›
last »